NEW CSRxP ANALYSIS: BIG PHARMA SPENDS THREE TIMES MORE ON PROFITS, ADVERTISING AND OVERHEAD THAN R&D
Breaking Down The “Big Pharma Dollar” Shows Brand Name Pharmaceutical… Read More

Breaking Down The “Big Pharma Dollar” Shows Brand Name Pharmaceutical… Read More
Big Pharma Giant Engages in Product Hopping Strategy to Game the Patent… Read More
Boosting Biosimilar Competition and Cracking Down on Big Pharma’s Egregious… Read More
New Report Underscores How Brand Name Drug Companies Ride High on Egregious… Read More
Bipartisan Solution Would Help Bring More Generics and Biosimilars to Market,… Read More
New Findings Underscore Broad-Based Support for Market-Based Solutions to Hold… Read More
Across Political Spectrum, Fabrizio Ward Finds Voters Identify Pharmaceutical… Read More
Voters Across the Political Spectrum Identify Pharmaceutical Company Profits… Read More
New Analysis Will Help Shine a Light on Big Pharma’s Increasingly… Read More
AARP Urges Lawmakers to Pass Cornyn-Blumenthal On Friday, AARP urged lawmakers… Read More
Lawmakers Unanimously Advance Bipartisan Solution to Help Hold Big Pharma… Read More
Broad-based Coalition of Advocates, Including AARP and Patients for Affordable… Read More